MDLN MEDLINE INC

Medline Announces Participation in J.P. Morgan 2026 Healthcare Conference

Medline Announces Participation in J.P. Morgan 2026 Healthcare Conference

NORTHFIELD, Ill., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that Jim Boyle, Chief Executive Officer, and Mike Drazin, Chief Financial Officer, are scheduled to present at the J.P. Morgan Healthcare Conference in San Francisco, Calif., on Tuesday, January 13, 2026, at 3:00 pm Pacific Time.

The presentation will be available on the page of Medline’s Investor Relations website at . A replay of the webcast will be available on Medline’s Investor Relations website for 30 days following the event.

About Medline

Medline is the largest provider of medical-surgical (“med-surg”) products and supply chain solutions serving all points of care, based on total net sales of med-surg products. Through its broad product portfolio, resilient supply chain and leading clinical solutions, Medline helps healthcare providers improve their clinical, financial and operational outcomes. Headquartered in Northfield, Illinois, the company employs more than 43,000 people worldwide and operates in more than 100 countries. For more information, visit .

  

Contacts

Investor Relations:

Karen King

Global Head of Investor Relations

Patrick Flaherty

Director, Investor Relations

(847) 247-7222

Media Relations:

Ben Fox

Vice President, Corporate Communications

(224) 327-9999

Source: Medline Inc.



EN
30/12/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on MEDLINE INC

 PRESS RELEASE

Medline Inc. announces launch of secondary offering of Class A common ...

Medline Inc. announces launch of secondary offering of Class A common stock NORTHFIELD, Ill., March 03, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (Nasdaq: MDLN) (“Medline”) announced today that certain selling stockholders affiliated with Blackstone Inc., The Carlyle Group Inc., Hellman & Friedman LLC and a wholly owned subsidiary of the Abu Dhabi Investment Authority (the “Selling Stockholders”) have commenced an underwritten public offering of 75,000,000 shares of Medline’s Class A common stock pursuant to a registration statement filed with the Securities and Exchange Commission (the “SEC”...

 PRESS RELEASE

Medline Reports Fourth Quarter and Full Year 2025 Results

Medline Reports Fourth Quarter and Full Year 2025 Results Delivered strong full year 2025 resultsCompleted Initial Public OfferingIntroduced full year 2026 guidanceFourth quarter net sales of $7.8 billion, an increase of 14.8%Fourth quarter net income of $180 million, a decrease of 37.7%Fourth quarter Adjusted EBITDA1 of $805 million, approximately flatFull year net sales of $28.4 billion, an increase of 11.5%Full year net income of $1.2 billion, a decrease of 3.6%Full year Adjusted EBITDA1 of $3.5 billion, an increase of 3.2% NORTHFIELD, Ill., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Medline I...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

 PRESS RELEASE

Medline announces participation in the Barclays 28th Annual Global Hea...

Medline announces participation in the Barclays 28th Annual Global Healthcare Conference NORTHFIELD, Ill., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that Jim Boyle, Chief Executive Officer, and Mike Drazin, Chief Financial Officer, are scheduled to present at the Barclays 28th Annual Global Healthcare Conference in Miami Beach, FL, on Wednesday, March 11, 2026, at 9:30am ET. A webcast of the presentation will be available on the  page of Medline’s Investor Relations website at . A replay of the webcast will be available on Medline’s Investo...

 PRESS RELEASE

Medline to report fourth quarter and full year 2025 results on Februar...

Medline to report fourth quarter and full year 2025 results on February 25, 2026 NORTHFIELD, Ill., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that it plans to report fourth quarter and full year 2025 financial results on Wednesday, February 25, 2026. A press release and supplemental materials will be issued before the market opens. The company will host a webcast and conference call at 9:30am ET/ 8:30am CT to discuss the financial results. Information about Medline’s financial results, including a link to the live webcast, will be available ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch